Search Results - "COLLINS, Sara D"

Complications and Outcome of Balloon Aortic Valvuloplasty in High-Risk or Inoperable Patients by Ben-Dor, Itsik, MD, Pichard, Augusto D., MD, Satler, Lowell F., MD, Goldstein, Steven A., MD, Syed, Asmir I., MD, Gaglia, Michael A., MD, MSc, Weissman, Gaby, MD, Maluenda, Gabriel, MD, Gonzalez, Manuel A., MD, MPH, Wakabayashi, Kohei, MD, Collins, Sara D., MD, Torguson, Rebecca, MPH, Okubagzi, Petros, MD, Xue, Zhenyi, MS, Kent, Kenneth M., MD, PhD, Lindsay, Joseph, MD, Waksman, Ron, MD

“…Objectives This study aimed to determine the success, complications, and survival of patients after balloon aortic valvuloplasty (BAV). Background The…”
Get full text

Relation of Proton Pump Inhibitor Use After Percutaneous Coronary Intervention With Drug-Eluting Stents to Outcomes by Gaglia, Michael A., MD, MSc, Torguson, Rebecca, MPH, Hanna, Nicholas, MD, Gonzalez, Manuel A., MD, MPH, Collins, Sara D., MD, Syed, Asmir I., MD, Ben-Dor, Itsik, MD, Maluenda, Gabriel, MD, Delhaye, Cedric, MD, Wakabayashi, Kohei, MD, Xue, Zhenyi, MS, Suddath, William O., MD, Kent, Kenneth M., MD, PhD, Satler, Lowell F., MD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…Recent evidence has shown that clopidogrel and proton pump inhibitors (PPIs) are metabolized by the same pathway and that patients taking both drugs have…”
Get full text

Impact of Chronic Obstructive Pulmonary Disease on Acute-Phase Outcome of Myocardial Infarction by Wakabayashi, Kohei, MD, Gonzalez, Manuel A., MD, MPH, Delhaye, Cedric, MD, Ben-Dor, Itsik, MD, Maluenda, Gabriel, MD, Collins, Sara D., MD, Syed, Asmir I., MD, Gaglia, Michael A., MD, MSc, Torguson, Rebecca, MPH, Xue, Zhenyi, MS, Suddath, William O., MD, Satler, Lowell F., MD, Kent, Kenneth M., MD, PhD, Lindsay, Joseph, MD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…Several reports have alluded to the adverse effect of chronic obstructive pulmonary disease (COPD) on long-term prognosis of patients with myocardial…”
Get full text

Does Black Ethnicity Influence the Development of Stent Thrombosis in the Drug-Eluting Stent Era? by COLLINS, Sara D, TORGUSON, Rebecca, KENT, Kenneth M, PICHARD, Augusto D, SUDDATH, William O, SATLER, Lowell F, WAKSMAN, Ron, GAGLIA, Michael A, LEMESLE, Gilles, SYED, Asmir I, BEN-DOR, Itsik, YANLIN LI, MALUENDA, Gabriel, KANESHIGE, Kimberly, ZHENYI XUE

“…It has been suggested that black race predicts stent thrombosis (ST) after drug-eluting stent implantation. Whether socioeconomic status or comorbid conditions…”
Get full text

Prognostic Value of Hemoglobin A1C Levels in Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention With Stent Implantation by Lemesle, Gilles, MD, Bonello, Laurent, MD, de Labriolle, Axel, MD, Maluenda, Gabriel, MD, Syed, Asmir I., MD, Collins, Sara D., MD, Ben-Dor, Itsik, MD, Torguson, Rebecca, MPH, Kaneshige, Kimberly, BS, Xue, Zhenyi, MS, Suddath, William O., MD, Satler, Lowell F., MD, Kent, Kenneth M., MD, PhD, Lindsay, Joseph, MD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…The optimal glycosylated hemoglobin (HbA1C) target in diabetic patients is a subject of ongoing controversy that may be especially pertinent in diabetic…”
Get full text

Incidence, correlates, and clinical impact of nuisance bleeding after antiplatelet therapy for patients with drug-eluting stents by Ben-Dor, Itsik, MD, Torguson, Rebecca, MPH, Scheinowitz, Mickey, PhD, Li, Yanlin, MD, Delhaye, Cedric, MD, Wakabayashi, Kohei, MD, Maluenda, Gabriel, MD, Syed, Asmir I., MD, Collins, Sara D., MD, Gonzalez, Manuel A., MD, MPH, Gaglia, Michael A., MD, MSc, Xue, Zhenyi, MS, Kaneshige, Kimberly, BS, Satler, Lowell F., MD, Suddath, William O., MD, Kent, Kenneth M., MD, PhD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…Background Nuisance bleeding (NB) after dual antiplatelet therapy (DAPT) is not well characterized despite its potential to impact patient compliance. We…”
Get full text

Long-Term Prognostic Value of Preprocedural C-Reactive Protein After Drug-Eluting Stent Implantation by Delhaye, Cedric, MD, Maluenda, Gabriel, MD, Wakabayashi, Kohei, MD, Ben-Dor, Itsik, MD, Lemesle, Gilles, MD, Collins, Sara D., MD, Syed, Asmir I., MD, Torguson, Rebecca, MPH, Kaneshige, Kimberly, BS, Xue, Zhenyi, MS, Suddath, William O., MD, Satler, Lowell F., MD, Kent, Kenneth M., MD, PhD, Lindsay, Joseph, MD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…C-reactive protein (CRP) elevation is associated with an adverse cardiovascular prognosis after bare metal stent implantation. Data have suggested a similar…”
Get full text

Utility of Radiologic Review for Noncardiac Findings on Multislice Computed Tomography in Patients With Severe Aortic Stenosis Evaluated for Transcatheter Aortic Valve Implantation by Ben-Dor, Itsik, MD, Waksman, Ron, MD, Hanna, Nicholas N., MD, Raizon, Arnold, MD, Satler, Lowell F., MD, Torguson, Rebecca, MPH, Weissman, Gaby, MD, Okubagzi, Petros, MD, Xue, Zhenyi, MS, Li, Yanlin, MD, Gonzalez, Manuel A., MD, MPH, Maluenda, Gabriel, MD, Gaglia, Michael A., MD, MSc, Wakabayashi, Kohei, MD, Delhaye, Cedric, MD, Syed, Asmir I., MD, Collins, Sara D., MD, Suddath, William O., MD, Kent, Kenneth M., MD, PhD, Lindsay, Joseph, MD, Pichard, Augusto D., MD

“…Transcatheter aortic valve implantation (TAVI) without replacement requires precise knowledge of the anatomic dimensions and physical characteristics of the…”
Get full text

Insurance Type Influences the Use of Drug-Eluting Stents by Gaglia, Michael A., MD, MSc, Torguson, Rebecca, MPH, Xue, Zhenyi, MS, Gonzalez, Manuel A., MD, MPH, Collins, Sara D., MD, Ben-Dor, Itsik, MD, Syed, Asmir I., MD, Maluenda, Gabriel, MD, Delhaye, Cedric, MD, Hanna, Nicholas, MD, Wakabayashi, Kohei, MD, Kaneshige, Kimberly, BS, Suddath, William O., MD, Kent, Kenneth M., MD, PhD, Satler, Lowell F., MD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…Objectives We sought to examine the effect of insurance type upon the likelihood of receiving a drug-eluting stent (DES). Background Recent guidelines suggest…”
Get full text

Prognostic Significance of Small Troponin I Rise After a Successful Elective Percutaneous Coronary Intervention of a Native Artery by De Labriolle, Axel, MD, Lemesle, Gilles, MD, Bonello, Laurent, MD, Syed, Asmir I., MD, Collins, Sara D., MD, Ben-Dor, Itsik, MD, Pinto Slottow, Tina L., MD, Xue, Zhenyi, MS, Torguson, Rebecca, MPH, Suddath, William O., MD, Satler, Lowell F., MD, Kent, Kenneth M., MD, Pichard, Augusto D., MD, Lindsay, Joseph, MD, Waksman, Ron, MD

“…Cardiac troponin I is a sensitive marker of myonecrosis. Data regarding the prognostic value of troponin I increase after percutaneous coronary intervention…”
Get full text

The clinical significance of hematocrit values before and after percutaneous coronary intervention by Maluenda, Gabriel, MD, Lemesle, Gilles, MD, Collins, Sara D., MD, Ben-Dor, Itsik, MD, Syed, Asmir I., MD, Torguson, Rebecca, MPH, Kaneshige, Kimberly, BS, Xue, Zhenyi, MS, Pakala, Rajbabu, PhD, Suddath, William O., MD, Satler, Lowell F., MD, Kent, Kenneth M., MD, PhD, Lindsay, Joseph, MD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…Background The presence of anemia before percutaneous coronary intervention (PCI) and/or the development of bleeding or anemia after PCI has been shown to…”
Get full text

Correlates and Consequences of Gastrointestinal Bleeding Complicating Percutaneous Coronary Intervention by Gaglia, Michael A., MD, MSc, Torguson, Rebecca, MPH, Gonzalez, Manuel A., MD, MPH, Ben-Dor, Itsik, MD, Maluenda, Gabriel, MD, Collins, Sara D., MD, Syed, Asmir I., MD, Delhaye, Cedric, MD, Wakabayashi, Kohei, MD, Belle, Loic, MD, Mahmoudi, Michael, MD, Hanna, Nicholas, MD, Xue, Zhenyi, MS, Kaneshige, Kimberly, BS, Suddath, William O., MD, Kent, Kenneth M., MD, PhD, Satler, Lowell F., MD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…Gastrointestinal bleeding (GIB) complicating percutaneous coronary intervention (PCI) results in high mortality, but clinical factors associated with and…”
Get full text

Three-Year Outcomes Following Sirolimus - Versus Paclitaxel -Eluting Stent Implantation in an Unselected Population With Coronary Artery Disease (from the REWARDS Registry) by Hanna, Nicholas N., MD, Gaglia, Michael A., MD, MSc, Torguson, Rebecca, MPH, Ben-Dor, Itsik, MD, Gonzalez, Manuel A., MD, MPH, Collins, Sara D., MD, Syed, Asmir I., MD, Maluenda, Gabriel, MD, Kaneshige, Kimberly, BS, Xue, Zhenyi, MS, Satler, Lowell F., MD, Kent, Kenneth M., MD, PhD, Suddath, William O., MD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…The Registry Experience at the Washington Hospital Center with Drug-Eluting Stents (REWARDS) study includes unselected patients with coronary artery disease…”
Get full text

Drug-Eluting Stents: Issues of Late Stent Thrombosis by Lemesle, Gilles, MD, Maluenda, Gabriel, MD, Collins, Sara D., MD, Waksman, Ron, MD

“…In in-stent restenosis, drug-eluting stents are superior compared with bare metal stents. However, there are concerns about safety because of the reports of…”
Get full text

A Novel Percutaneous Coronary Intervention Risk Score to Predict One-Year Mortality by Maluenda, Gabriel, MD, Delhaye, Cedric, MD, Gaglia, Michael A., MD, MSc, Ben-Dor, Itsik, MD, Gonzalez, Manuel A., MD, MPH, Hanna, Nicholas N., MD, Collins, Sara D., MD, Wakabayashi, Kohei, MD, Torguson, Rebecca, MPH, Xue, Zhenyi, MS, Satler, Lowell F., MD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…Clinical and angiographic risk factors associated with adverse outcomes after percutaneous coronary intervention (PCI) have been included in previous validated…”
Get full text

Safety and In-Hospital Outcomes of Bivalirudin Use in Dialysis Patients Undergoing Percutaneous Coronary Intervention by Delhaye, Cedric, MD, Maluenda, Gabriel, MD, Wakabayashi, Kohei, MD, Ben-Dor, Itsik, MD, Collins, Sara D., MD, Syed, Asmir I., MD, Gonzalez, Manuel A., MD, Gaglia, Michael A., MD, Torguson, Rebecca, MPH, Xue, Zhenyi, MS, Suddath, William O., MD, Satler, Lowell F., MD, Kent, Kenneth M., MD, PhD, Lindsay, Joseph, MD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…Chronic dialysis-dependent patients undergoing percutaneous coronary intervention (PCI) are at a greater risk of bleeding and ischemic events. Bivalirudin has…”
Get full text

Effect of Drug-Eluting Stents on Frequency of Repeat Revascularization in Patients With Unstable Angina Pectoris or Non-ST-Elevation Myocardial Infarction by Li, Yanlin, MD, Torguson, Rebecca, MPH, Syed, Asmir I., MD, Ben-Dor, Itsik, MD, Collins, Sara D., MD, Maluenda, Gabriel, MD, Scheinowitz, Mickey, PhD, Kaneshige, Kimberly, BS, Xue, Zhenyi, MS, Lemesle, Gilles, MD, Satler, Lowell F., MD, Suddath, William O., MD, Kent, Kenneth M., MD, PhD, Lindsay, Joseph, MD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…Drug-eluting stents (DES) have been shown to markedly reduce the need for repeat revascularization compared to bare-metal stents in patients with stable…”
Get full text

Effects of Percutaneous Aortic Valve Replacement on Coronary Blood Flow Assessed With Transesophageal Doppler Echocardiography in Patients With Severe Aortic Stenosis by Ben-Dor, Itsik, MD, Goldstein, Steven A., MD, Waksman, Ron, MD, Satler, Lowell F., MD, Li, Yanlin, MD, Syed, Asmir I., MD, Maluenda, Gabriel, MD, Collins, Sara D., MD, Suddath, William O., MD, Torguson, Rebecca, MPH, Xue, Zhenyi, MS, Kaneshige, Kimberly, BS, Okubagzi, Petros, MD, Wang, Zuyue, MD, Kent, Kenneth M., MD, PhD, Pichard, Augusto D., MD

“…The aim of this study was to assess the change in coronary flow in patients who underwent percutaneous aortic valve replacement (PAVR) for severe aortic…”
Get full text

Outcomes in Diabetic Versus Nondiabetic Patients Who Present With Acute Myocardial Infarction and Are Treated With Drug-Eluting Stents by Syed, Asmir I., MD, Ben-Dor, Itsik, MD, Li, Yanlin, MD, Collins, Sara D., MD, Gonzalez, Manuel A., MD, MPH, Gaglia, Michael A., MD, Maluenda, Gabriel, MD, Delhaye, Cedric, MD, Wakabayashi, Kohei, MD, Bonello, Laurant, MD, De Labriolle, Axel, MD, Belle, Loic, MD, Torguson, Rebecca, MPH, Xue, Zhenyi, MS, Kaneshige, Kimberly, BS, Bernardo, Nelson, MD, Satler, Lowell F., MD, Kent, Kenneth M., MD, PhD, Suddath, William O., MD, Pichard, Augusto D., MD, Lindsay, Joseph, MD, Waksman, Ron, MD

“…Patients with diabetes mellitus (DM) are at a greater risk of mortality and cardiovascular events after percutaneous coronary intervention than those without…”
Get full text

Clinical Profile, Treatment Assignment and Clinical Outcome of Patients With Severe Aortic Stenosis Not Eligible to Participate in a Clinical Trial of Percutaneous Aortic Valve Replacement by Ben-Dor, Itsik, MD, Pichard, Augusto D., MD, Satler, Lowell F., MD, Okubagzi, Petros, MD, Torguson, Rebecca, MPH, Xue, Zhenyi, MS, Kaneshige, Kimberly, BS, Goldstein, Steven A., MD, Syed, Asmir I., MD, Li, Yanlin, MD, Lemesle, Gilles, MD, Maluenda, Gabriel, MD, Collins, Sara D., MD, Wang, Zuyue, MD, Suddath, William O., MD, Kent, Kenneth M., MD, PhD, Lindsay, Joseph, MD, Waksman, Ron, MD

“…Patients with severe aortic stenosis and considered at high surgical risk or inoperable, and not eligible for a randomized clinical trial evaluating…”
Get full text